Literature DB >> 8801210

Hepatitis C virus: epidemiology and genotypes in the north east of England.

J P Watson1, A M Brind, C E Chapman, C L Bates, F K Gould, S J Johnson, A D Burt, J Ferguson, P Simmonds, M F Bassendine.   

Abstract

The epidemiology of hepatitis C virus (HCV) infection was studied in an English teaching hospital over an 18 month period. A total of 104 HCV antibody positive patients were referred for further investigation. They were divided into those diagnosed through screening (blood donors and intravenous drug abusers) and those diagnosed for other reasons, and their mean ages, known risk factors for HCV transmission, genotypes, and liver biopsy histology were analysed. Screened patients were significantly younger than the others. No significant difference in age was found between genotypes. Most patients genotyped (69%) were genotype 1. Intravenous drug abusers had a higher proportion of subtype 1a, and patients who acquired HCV through blood transfusion had a higher proportion of subtype 1b. Liver biopsy specimens were scored using a histological activity index for liver inflammation and fibrosis. Patients with subtype 1b had significantly more severe liver disease than other genotypes when the histological activity index scores for fibrosis were analysed (p < 0.05). Liver disease worsened significantly with age according to all three histological activity index scores (portal activity: p < 0.01, acinar activity: p < 0.001, fibrosis: p < 0.0001). Liver disease worsened with increased duration of infection (p < 0.002), and patients who also abused alcohol presented at a significantly younger age (cirrhosis, p < 0.05, hepatocellular carcinoma, p < 0.02).

Entities:  

Mesh:

Year:  1996        PMID: 8801210      PMCID: PMC1383036          DOI: 10.1136/gut.38.2.269

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity.

Authors:  D J Mutimer; R F Harrison; K B O'Donnell; J Shaw; B A Martin; H Atrah; F A Ala; S Skidmore; S G Hubscher; J M Neuberger
Journal:  BMJ       Date:  1994-10-01

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Prognosis of chronic persistent hepatitis.

Authors:  M D Becker; A Baptista; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1970-01-10       Impact factor: 79.321

4.  Asymptomatic hepatitis C infection. Hepatitis C can be sexually transmitted.

Authors:  S Curtis
Journal:  BMJ       Date:  1994-05-07

5.  A proposed system for the nomenclature of hepatitis C viral genotypes.

Authors:  P Simmonds; A Alberti; H J Alter; F Bonino; D W Bradley; C Brechot; J T Brouwer; S W Chan; K Chayama; D S Chen
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

Review 6.  Hepatitis C virus six years on.

Authors:  C L van der Poel; H T Cuypers; H W Reesink
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

7.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.

Authors:  I Saito; T Miyamura; A Ohbayashi; H Harada; T Katayama; S Kikuchi; Y Watanabe; S Koi; M Onji; Y Ohta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates.

Authors:  J A Garson; P W Tuke; M Makris; M Briggs; S J Machin; F E Preston; R S Tedder
Journal:  Lancet       Date:  1990-10-27       Impact factor: 79.321

9.  Chronic persistent hepatitis. Long-term prospective study on the natural course of the disease.

Authors:  B Vucelić; N Hadzić; D Dubravcić
Journal:  Scand J Gastroenterol       Date:  1988-06       Impact factor: 2.423

10.  Low prevalence of antibody to hepatitis C virus in north east England.

Authors:  A M Brind; A A Codd; B J Cohen; F G Gabriel; J D Collins; O F James; M F Bassendine
Journal:  J Med Virol       Date:  1990-12       Impact factor: 2.327

View more
  11 in total

1.  Screening asymptomatic people at high risk for hepatitis C. The case for.

Authors:  C A Seymour
Journal:  BMJ       Date:  1996-05-25

2.  Alanine aminotransferase assay to detect anti-HCV positive subjects in non-selected populations.

Authors:  V Guadagnino; T Stroffolini; M Rapicetta; E Gulletta
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

3.  Clinical relevance of hepatitis C virus genotypes.

Authors:  P Simmonds
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 4.  The long-term horizon: Patients who will remain untreated in the era of triple therapy.

Authors:  Andrew Aronsohn; Donald Jensen
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-03-06

5.  Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters.

Authors:  J P Allain; Y Dong; A M Vandamme; V Moulton; M Salemi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype.

Authors:  I Nakano; Y Fukuda; Y Katano; H Toyoda; K Hayashi; T Hayakawa; T Kumada; S Nakano
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

7.  Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.

Authors:  S Bellentani; G Pozzato; G Saccoccio; M Crovatto; L S Crocè; L Mazzoran; F Masutti; G Cristianini; C Tiribelli
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

Review 8.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 9.  Predictors for dose reduction of antiviral therapy in older patients infected with hepatitis C virus: a meta-regression analysis.

Authors:  H Zhou; H Luo; S Xiao; H Wang; G Gong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-06       Impact factor: 3.267

Review 10.  Hepatitis C virus infection in the elderly: epidemiology, natural history and management.

Authors:  Francesca Cainelli
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.